Fluvoxamine Maleate Extended-Release Capsules Shortage
Last Updated: December 18, 2024
Status: Current
Products Affected - Description
-
- Fluvoxamine maleate extended release capsule, Teva, 100 mg, bottle, 30 count, NDC 00228-2848-03
- Fluvoxamine maleate extended release capsule, Teva, 150 mg, bottle, 30 count, NDC 00228-2849-03
Reason for the Shortage
-
- Par has fluvoxamine extended-release capsules available.
- Teva did not provide a reason for the shortage.
Available Products
-
- Fluvoxamine maleate extended release capsule, Par Pharmaceuticals, 100 mg, bottle, 30 count, NDC 10370-0175-11
- Fluvoxamine maleate extended release capsule, Par Pharmaceuticals, 150 mg, bottle, 30 count, NDC 10370-0176-11
Estimated Resupply Dates
-
- Teva has fluvoxamine 100 mg and 150 mg extended-release capsules on back order and the company estimates a release date of late-December 2024.
Updated
Updated December 18, 2024 by Michelle Wheeler, PharmD, Drug Information Specialist. Created February 13, 2024 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.